Results from 2 randomized, double-blind, placebo-controlled studies of the novel nk1 receptor antagonist casopitant in patients with major depressive disorder

由 Ratti, E., Bellew, K., Bettica, P., Bryson, H., Zamuner, S., Archer, G., Squassante, L., Bye, A., Trist, D., Krishnan, K.R., Fernandes, S.
出版 2014

Full central neurokinin-1 receptor blockade is required for efficacy in depression: Evidence from orvepitant clinical studies

由 Ratti, E., Bettica, P., Alexander, R., Archer, G., Carpenter, D., Evoniuk, G., Gomeni, R., Lawson, E., Lopez, M., Millns, H., Rabiner, E.A., Trist, D., Trower, M., Zamuner, S., Krishnan, R., Fava, M.
出版 2014